MOTOHASHI N[au] - Search Results

Year	Number of Results
1964	1
1965	1
1975	1
1976	3
1977	5
1978	3
1979	2
1981	5
1982	5
1983	6
1984	2
1985	2
1986	6
1987	2
1988	3
1989	3
1990	6
1991	7
1992	12
1993	11
1994	8
1995	15
1996	15
1997	16
1998	11
1999	16
2000	13
2001	17
2002	20
2003	19
2004	21
2005	12
2006	22
2007	11
2008	6
2009	7
2010	7
2011	6
2012	6
2013	5
2014	7
2015	8
2017	3
2018	3
2019	4
2020	2
2021	3
2022	2

1

Isolation, culture, and transplantation of muscle satellite cells.

Motohashi N, Asakura Y, Asakura A. Motohashi N, et al. J Vis Exp. 2014 Apr 8;(86):50846. doi: 10.3791/50846. J Vis Exp. 2014. PMID: 24747722 Free PMC article.

2

[Meige's syndrome].

Kimura M, Motohashi N. Kimura M, et al. Among authors: motohashi n. Ryoikibetsu Shokogun Shirizu. 2003;(38):196-8. Ryoikibetsu Shokogun Shirizu. 2003. PMID: 12876964 Review. Japanese. No abstract available.

3

Cytotoxic potential of phenothiazines.

Motohashi N, Kawase M, Satoh K, Sakagami H. Motohashi N, et al. Curr Drug Targets. 2006 Sep;7(9):1055-66. doi: 10.2174/138945006778226624. Curr Drug Targets. 2006. PMID: 17017885 Review.

4

Potential antitumor phenoxazines.

Motohashi N, Mitscher LA, Meyer R. Motohashi N, et al. Med Res Rev. 1991 May;11(3):239-94. doi: 10.1002/med.2610110302. Med Res Rev. 1991. PMID: 2056806 Review.

5

[Recommendations for ECT Practice, Second Edition].

Motohashi N, Awata S, Isse K, Ueda S, Okubo Y, Okumura M, Kashima H, Kawasaki H, Sameshima T, Sawa Y, Takebayashi M, Hatta K, Wakejima T, Wada K, Yamaguchi N, Yoneda H. Motohashi N, et al. Seishin Shinkeigaku Zasshi. 2013;115(6):586-600. Seishin Shinkeigaku Zasshi. 2013. PMID: 23944116 Review. Japanese. No abstract available.

6

Antitumor properties of phenothiazines.

Motohashi N, Gollapudi SR, Emrani J, Bhattiprolu KR. Motohashi N, et al. Cancer Invest. 1991;9(3):305-19. doi: 10.3109/07357909109021328. Cancer Invest. 1991. PMID: 1913233 Review.

7

Muscle satellite cell heterogeneity and self-renewal.

Motohashi N, Asakura A. Motohashi N, et al. Front Cell Dev Biol. 2014 Jan 30;2:1. doi: 10.3389/fcell.2014.00001. eCollection 2014. Front Cell Dev Biol. 2014. PMID: 25364710 Free PMC article. Review.

8

[Selective serotonin reuptake inhibitor(SSRI)].

Motohashi N. Motohashi N. Nihon Rinsho. 2001 Aug;59(8):1519-22. Nihon Rinsho. 2001. PMID: 11519151 Review. Japanese.

9

Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice.

Nogami K, Maruyama Y, Sakai-Takemura F, Motohashi N, Elhussieny A, Imamura M, Miyashita S, Ogawa M, Noguchi S, Tamura Y, Kira JI, Aoki Y, Takeda S, Miyagoe-Suzuki Y. Nogami K, et al. Among authors: motohashi n. Hum Mol Genet. 2021 May 31;30(11):1006-1019. doi: 10.1093/hmg/ddab100. Hum Mol Genet. 2021. PMID: 33822956 Free PMC article.

10

[History and present status of electroconvulsive therapy].

Motohashi N. Motohashi N. Seishin Shinkeigaku Zasshi. 2007;109(4):361-4. Seishin Shinkeigaku Zasshi. 2007. PMID: 17561677 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results